Original Research

Lumbar Fusion With Polyetheretherketone Rods Use for Patients With Degenerative Disease

Author and Disclosure Information

 

References

Patient Reported Outcomes

Recent large studies were reviewed to assess the pre- and postoperative patient PROs reported in comparison with our study population (Table 4). In the Swedish Spine Registry analysis of 765 patients with 3 different types of lumbar fusion, the mean preoperative ODI score was 37 and mean SF-36 physical component score (PCS) was 35 for the most similar approach (posterolateral fusion with instrumentation).25 At 1 year postoperation, the mean ODI was 26 and mean SF-36 PCS was 43. In the Spine Patient Outcomes Research Trial (SPORT) spondylolisthesis trial of 3 fusion types, the mean preoperative ODI was 41.2 and mean SF-36 PF score was 31.2 for the most similar approach (posterolateral instrumented fusion with pedicle screws).26 Postoperative ODI scores at 1 year decreased by a mean 20.9 points and mean SF-36 PF scores increased by 29.9.

Study Score Comparisons

We report a mean preoperative SF-36 PF score of 28.9, which is lower than the SPORT study score for posterolateral fusion with instrumentation and the Swedish Study score for posterolateral instrumented fusion with pedicle screws. Similarly, our mean ODI score of 24.8 was better than the scores reported in the Swedish and SPORT studies. Our mean SF-36 PF score at 1 year postoperation was 59.3, compared with 58.5 for the SPORT study group and 46.0 in the Swedish study group. Mean ODI score at 1 year postoperatively was 14.5, which is better than the scores reported in the Swedish and SPORT studies.

Minimally clinically important difference (MCID) is a parameter used to gauge the efficacy of spine surgery. The utility of the MCID based upon PROs has been questioned in lumbar fusion surgery, as it has been thought to measure if the patient is “feeling” rather than “doing” better, the latter of which can be better measured by functional performance measures and objective, external socioeconomic anchors such as return to work and health care costs.27 Nevertheless, validated PROs are reported widely in the spine surgery literature. The MCID in the SF-36 is not well established and can depend upon whether the scores are at the extremes or more in the central range and whether there is large variability in the scores.28 Rheumatoid arthritis was estimated to be 7.1 points on the PF scale and 7.2 on the physical component summary (PCS).29 For total knee replacement, it has been estimated to be 10 points on the SF-36 PCS.30 Lumbar surgery was estimated to be 4.9 points for the SF-36 PCS and 12.8 points for the ODI.31 And the SPORT trial it has been estimated that a 30% change in the possible gain (or loss) may be an appropriate criterion.28

With a preoperative mean SF-36 PF of 28.9, a 30% improvement in the available range (70.1) would be 21 points, making our data mean improvement of 30 points above the MCID. With a mean preoperative ODI of 24.6, a 30% improvement in the available range (25.4) would be 7.6 points, making our data mean improvement of 10.3 points better than the MCID. Therefore, our outcome results are comparable with other lumbar fusion outcome studies in terms of degree of disability prior to surgery and amount of improvement from surgery.

Pages

Recommended Reading

The Multiple Sclerosis Centers of Excellence: A Model of Excellence in the VA (FULL)
Federal Practitioner
The Multiple Sclerosis Surveillance Registry: A Novel Interactive Database Within the Veterans Health Administration (FULL)
Federal Practitioner
Behavioral Interventions in Multiple Sclerosis
Federal Practitioner
Multiple Sclerosis Medications in the VHA: Delivering Specialty, High-Cost, Pharmacy Care in a National System (FULL)
Federal Practitioner
The Future of Progressive Multiple Sclerosis Therapies (FULL)
Federal Practitioner
Can supplementary estrogen relieve MS symptoms in menopausal women?
Federal Practitioner
Cannabinoids promising for improving appetite, behavior in dementia
Federal Practitioner
Green light puts the stop on migraine
Federal Practitioner
Age-related cognitive decline not inevitable?
Federal Practitioner
COVID-19 Vaccine in Veterans with Multiple Sclerosis: Protect the Vulnerable
Federal Practitioner

Related Articles